Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Vanda (VNDA) Q4 2025 Earnings Call Transcript
↗
Today 18:21 EST
Via
The Motley Fool
Topics
Earnings
Tickers
VNDA
Exposures
Financial
Product Safety
The Unsung Heroes of the Stage: Greg Nelson Goes “Behind the Sound” on the Blue Collar Trade Show Podcast
Today 17:33 EST
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
420 with CNW — Deadline Looms for the FDA to Publish Cannabinoids List
Today 16:25 EST
Via
CannabisNewsWire
Topics
Cannabis
Tickers
ACB
TSX:ACB
Exposures
Cannabis
Product Safety
420 with CNW — Deadline Looms for the FDA to Publish Cannabinoids List
Today 16:25 EST
Via
Investor Brand Network
Topics
Cannabis
Tickers
ACB
TSX:ACB
Exposures
Cannabis
Product Safety
The Evolution of Emergency Preparedness: Why Tactical Trauma Kits Are Replacing Standard First Aid Boxes in 2026
Today 15:41 EST
Via
AB Newswire
Exposures
Product Safety
PolyPid (PYPD) Q4 2025 Earnings Call Transcript
↗
Today 13:49 EST
Via
The Motley Fool
Topics
Earnings
Tickers
PYPD
Exposures
Financial
Product Safety
The Compliance Multiplier: How Full Service Logistics Reduces Regulatory Risk Across the Supply Chain
Today 10:40 EST
Via
GetFeatured
Topics
Economy
Product Recall
Supply Chain
Exposures
Legal
Product Safety
Supply Chain
Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients
↗
Today 10:26 EST
Via
Benzinga
Exposures
Product Safety
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
Today 10:11 EST
Via
The Motley Fool
Topics
Artificial Intelligence
Tickers
CVS
JPM
LLY
NVDA
NVO
RGNX
Exposures
Artificial Intelligence
Product Safety
Ford Motor Company (F) Deep Dive: Navigating the Hybrid Pivot and the Future of Ford Pro
Today 9:58 EST
Via
Finterra
Topics
Bankruptcy
Economy
Electric Vehicles
Tickers
ARM
BYDDY
F
GM
LCID
SQ
Exposures
Electric Vehicles
Financial
Interest Rates
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
Today 9:52 EST
Via
Finterra
Topics
Artificial Intelligence
Tickers
BDX
BLK
DGX
GLW
LH
Exposures
Artificial Intelligence
COVID-19
Product Safety
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
Today 9:48 EST
Via
Finterra
Topics
Economy
Intellectual Property
Tickers
ABBV
BLK
BMY
GSK
INCY
LLY
Exposures
Intellectual Property
Interest Rates
Product Safety
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
Today 9:42 EST
Via
Finterra
Topics
Artificial Intelligence
Initial Public Offering
Intellectual Property
Tickers
ARM
BNTX
MRNA
PFE
SQ
Exposures
Artificial Intelligence
COVID-19
Intellectual Property
Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset
Today 9:34 EST
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Tickers
BAX
BDX
BLK
JPM
MDT
RY
Exposures
Artificial Intelligence
Intellectual Property
Legal
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
Today 9:25 EST
Via
Newsfile
Tickers
ASX:COH
COCH
Exposures
Product Safety
Veru (VERU) Q1 2026 Earnings Call Transcript
↗
Today 8:53 EST
Via
The Motley Fool
Topics
Earnings
Tickers
VERU
Exposures
Financial
Product Safety
FDA Refuses To Review Moderna's Influenza Shot Application
↗
Today 5:21 EST
Via
Benzinga
Exposures
Product Safety
Nasdaq, S&P 500 Futures Rise Ahead Of Delayed Jobs Data: Why NVDA, WBD, HOOD, MRNA, ASTS Are On Traders' Radar Today
↗
Today 3:48 EST
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Stocks
Tickers
ASTS
CSCO
DIA
F
HOOD
IVZ
Exposures
Artificial Intelligence
Product Safety
US Equities
5 Insightful Analyst Questions From Bio-Techne’s Q4 Earnings Call
Today 0:36 EST
Via
StockStory
Topics
Earnings
Tickers
TECH
Exposures
Financial
Product Safety
Aloe Products Center Provides Natural Defense with Their Cancer Cure Supplement
February 10, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
Why Did Moderna Stock Tumble Nearly 10% After Hours Today?
↗
February 10, 2026
Via
Stocktwits
Tickers
MRNA
NVAX
Exposures
Product Safety
Exelixis (EXEL) Q4 2025 Earnings Call Transcript
↗
February 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
EXEL
Exposures
Financial
Product Safety
Stock Market Today, Feb. 10: Ford Holds Steady as Investors Await Q4 Earnings and 2026 Profitability Outlook
↗
February 10, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Product Recall
Stocks
Tickers
F
GM
STLA
Exposures
Legal
Product Safety
Securities Market
Moderna Takes It On The Chin After FDA Rejects Its Messenger-RNA-Based Flu Shot
↗
February 10, 2026
Via
Investor's Business Daily
Exposures
Product Safety
'I Know I'm Going to Be Wealthy': Warren Buffett's Son Recalls What His Father Said In His 20s
↗
February 10, 2026
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Tickers
AZN
LLY
MRK
NVO
Exposures
Artificial Intelligence
Financial
Product Safety
Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients
↗
February 10, 2026
Via
Benzinga
Exposures
Product Safety
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Tickers
ACLX
AZN
BLK
BMY
GILD
GSK
Exposures
Intellectual Property
Interest Rates
Product Safety
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Application for NV-387 as Measles Treatment
February 10, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Product Safety
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing
February 10, 2026
Via
NewMediaWire
Tickers
HYDI
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.